Solikhah Solikhah
Biographic Data
| ID | 10013840 |
|---|---|
| NAME | Solikhah Solikhah |
| GIVEN NAMES | Solikhah |
| FAMILY NAME | Solikhah |
| SIGNATURE | SOLIKHAH S |
| AFFILIATIONS | Universitas Ahmad Dahlan |
| ORCID | 0000-0001-6895-6840 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021
BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…
Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients
Background: Breast cancer is one of the most important health problems worldwide. Quality of life (QoL) is an important indicator to evaluate symptoms in cancer patients, including those with breast cancer. Culturally suitable, valid, reliable, and appropriate instruments to measure the QoL of breast cancer patients are needed, which is still rare in Indonesia. This study aimed to translate the EORTC QLQ-BR45 instrument into Indonesian and evalua…
No prominent works on this page.
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…
Cross-cultural adaptation and psychometric properties of the Indonesian version for quality of life among breast cancer patients
Background: Breast cancer is one of the most important health problems worldwide. Quality of life (QoL) is an important indicator to evaluate symptoms in cancer patients, including those with breast cancer. Culturally suitable, valid, reliable, and appropriate instruments to measure the QoL of breast cancer patients are needed, which is still rare in Indonesia. This study aimed to translate the EORTC QLQ-BR45 instrument into Indonesian and evalua…
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021
BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…
Medicine (3 works) · Burden of disease (2 works) · Disease (2 works) · Environmental health (2 works) · Pathology (2 works) · Bacterial Infections and Vaccines (1 work) · Breast cancer (1 work) · Cancer (1 work) · Cancer survivorship and care (1 work) · Cancer-related cognitive impairment studies (1 work)